Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05578378 Background | Jan 2022 → Dec 2023 | acute lymphoblastic leukemia | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “G-CSF will be hypodermic injection on day0-5,4 weeks per cycle.” NCT05578378 ↗ |
| Route | Subcutaneous | “G-CSF will be hypodermic injection on day0-5” NCT05578378 ↗ |